G rowing and Joining Using Molecular F ields Dr Martin J Slater Cresset BMD W ho are we Cresset was founded in 2002 by innovator Andy Vinter We provide and continually develop a suite of unique cutting edge molecular ID: 933704
Download Presentation The PPT/PDF document "Fast Computational M ethod for Fragment" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Fast Computational Method for Fragment Growing and Joining Using Molecular Fields
Dr Martin J Slater
Slide2Cresset BMD: Who are we?
Cresset was
founded
in 2002 by innovator Andy Vinter We provide and continually develop a suite of unique cutting edge molecular modelling software for drug discovery.We have clients from big pharma, agrochem, biotech and academia
Slide3Cresset’s unique technology
It uses a condensed 3D representation
of
the electrostatic, hydrophobic and shape properties of molecules together with the full fields.
3D
Molecular Electrostatic
Potential (MEP
)
What proteins see?
Field Points2D
RepresentationWhat chemists see?
= Positive
= Negative
= Shape
=
Hydrophobic
What
our CPUs
see?
Slide4Field patterns from Cresset’s proprietary XED force field reproduce experimental results
XEDs make
fields
workInteraction of Acetone and Any-OH from small molecule crystal structuresExperimentalUsing XEDs
Not using XEDs
XED adds p-orbitals to get better representation of atoms
Slide5Biologically
Relevant Molecular Comparisons
Bioisosteres
Bioisosteric groups
Slide6View
fields
Field points give you new insights into your molecule
Experimental
(Data from small molecule
xray
structures)
Fields
Structure
Slide7Comparing 2D and 3D metrics
Similar
2D=3D_FS
2D=3DDissimilar 2D=3D_FS2D = 3D_FS
Slide8Example - Higher 3D Sim
2D sim =
0.1
(other methods=0.3)
3D field sim = 0.82
Slide9Example - Higher 3D Sim
141
2D sim =
0.23D sim = 0.7454
Slide10Spark’s Approach
Rofecoxib
Valdecoxib
Etoricoxib12nM
Find
bioisosteres
by replacing sections of the molecule
Slide11Spark’s Approach
Select
a region to
replace and remove these atoms
Slide12Wrong distance
Spark’s Approach
Select
a region to replace and remove these atomsSearch database for matching fragments(geometric search only)(search runs on fragment conformations)
Slide13Spark’s Approach
Wrong angle
Select
a region to replace and remove these atomsSearch database for matching fragments(geometric search only)(search runs on fragment conformations)
Slide14Select a region to
replace and remove these atoms
Search
database for matching fragments geometric search only (search runs on fragment conformations)Form Products minimise and add field pointsSpark’s ApproachGood match
Slide15Select a region to
replace and remove these atoms
Search
database for matching fragmentsgeometric search onlysearch runs on fragment conformationsForm Productsminimise and add field pointsScoreSpark’s Approach0.88
Slide16Produces more diverse, non-obvious bioisosteresAvoids fragment scoring limitationsAllows for electronic influence of replacing a moiety on the rest of the molecule and vice versa
Allows for neighbouring group effects
Whole-Molecule Scoring Advantages
Slide17Example - COX-2Search for Bioisosteres for cyclic lactone of
Rofecoxib
Actives:
9 of the first 10 clusters21 of the first 30 clusters Search Common Dbs87,225 frags
Slide18Cluster,
Result
NosCluster idFieldStere result2D simclosest lit compd10,120.52Same, 60nM
13,19
0.509
7nM32
, 104
0.48
NoneCOX-2 Results
Cluster,
Result Nos
Cluster idSPARK result
2D sim
closest lit compd1,1
0.646
2,2
0.531
6.5uM
5,5
0.500
Same, 10nM
9,11
0.532
70nM
Slide19Scaffold replacement ‘Sildanafil’
s
park (10
mins)NEAT?spark results 2-5Fsim score
0.985
0.985
0.9820.978
spark results 6, 7, 10, 13
Fsim
score
0.973
0.973
0.959
0.957
spark results 14, 18, 26, 30
Fsim
score
0.953
0.951
0.943
0.939
Pfizer J
. Chem. Inf.
Model. 2012
Slide20Fragment growing example
FieldStere
version
3.0.0 fragment growth example:P38 kinase bound to a fragment fluorescent probe PDB:3K3I specific to the ‘DFG-out’ conformation ‘DFG-in’ example with specificity towards the ‘Gly’ flipped hinge PDB:3ROC and/or 3HUBSelectivity potentially to be gained by combining ‘Gly flip’ and ‘DFG-out’ in one moleculeCan we use the new version of SparkV10 to grow the DFG-out fragment into the DFG-in hinge?
Slide21Fragment in DFG-out pocket, PDB:3K3I
predominant hinge
c
onformationGraphics from Pymol from Delano Scientific
Slide22+Gly hinge flip ligand_1, PDB:3ROC
Hinge
Gly
flipGraphics from Pymol from Delano Scientific
Slide23Fragment compatibility – DFG-out
Slide24Structure
Rank
Sim
StructureRank
Sim
1
0.528
11
0.492
4
0.507
13
0.489
6
0.501
53
0.476
Fieldstere
output: 2D
mols
Slide25Fieldstere output: 3D mols and fields
Fragment and reference
Rank 4
Rank 6
Rank 11
Rank 13
Rank 53
Slide26OutcomeFragment growth both possible and a facile using an automated
process
with
SparkV10Interesting and sensible candidate molecules generatedPredict highly selective p38 activesAbsolute requirement for 3D insight
Slide27Any relevance? – Pfizer compound for COPD
Deposited in PDB
: 2YIS
November 2011Clinical trials for COPDVirtual compounds in the output list……prepared for ACS San Diego Late Summer 2011
Slide28ConclusionCresset offer a wide variety of software and collaborative solutions for drug discovery
Cutting edge technology
Provide
key insights
Slide29martin@cresset-group.comQuestions welcomed
Slide30COX-2 Results
Slide31Product Space
Target
Result 5
Result 1,484
Slide32+Gly hinge flip ligand_2, PDB:3HUB
Hinge
Gly
flip